文献速递妇科

绝经前双侧卵巢切除术后新发癌症的风险

Risk of de novo cancer after premenopausal bilateral oophorectomy.
PubMed 文献 · Am J Obstet Gynecol · 2021-11-10

该基于人群的队列研究纳入1988年至2007年明尼苏达州奥姆斯特德县50岁前因非恶性指征行双侧卵巢切除术的绝经前女性1562例及年龄匹配的对照女性1610例,中位随访18年。双侧卵巢切除术组任何癌症风险与对照组无显著差异(校正风险比0.82,95%CI 0.66-1.03),妇科癌症风险降低(校正风险比0.15,95%CI 0.06-0.34),非妇科癌症风险无差异(校正风险比0.99,95%CI 0.78-1.26)。

要点

  • 绝经前双侧卵巢切除术不降低任何癌症的总体风险(校正HR 0.82,95%CI 0.66-1.03)。
  • 双侧卵巢切除术降低妇科癌症风险(校正HR 0.15,95%CI 0.06-0.34),但不降低非妇科癌症风险(校正HR 0.99,95%CI 0.78-1.26)。
  • 卵巢癌平均风险女性不应为预防乳腺癌或其他非妇科癌症而考虑双侧卵巢切除术。

核心结论

  • 绝经前行双侧卵巢切除术的女性妇科癌症风险降低,但包括乳腺癌在内的其他类型癌症风险不降低。
  • 卵巢癌平均风险女性不应为预防乳腺癌或其他非妇科癌症而考虑双侧卵巢切除术。

研究设计与样本

  • 基于人群的队列研究,纳入1988年1月1日至2007年12月31日明尼苏达州奥姆斯特德县50岁前因非恶性指征行双侧卵巢切除术的绝经前女性1562例,以及年龄匹配(±1岁)的随机对照样本1610例未行双侧卵巢切除术的女性。
  • 排除卵巢切除术前(或索引日期前)或索引日期后6个月内患癌症的女性,采用时间-事件分析评估新发癌症风险,癌症诊断和类型通过病历审查确认。

主要发现

  • 中位随访18年,双侧卵巢切除术组与对照组任何癌症风险无显著差异(校正风险比0.82,95%CI 0.66-1.03)。
  • 双侧卵巢切除术组妇科癌症风险降低(校正风险比0.15,95%CI 0.06-0.34),非妇科癌症风险无差异(校正风险比0.99,95%CI 0.78-1.26)。
  • 乳腺癌、胃肠道癌症和肺癌风险在两组间无差异。
  • 双侧卵巢切除术组女性使用雌激素治疗至50岁未改变结果。

临床怎么用

  • 卵巢癌平均风险女性不应为预防乳腺癌或其他非妇科癌症而考虑双侧卵巢切除术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hysterectomy is one of the most frequent gynecologic surgeries in the United States. Women undergoing hysterectomy are commonly offered bilateral oophorectomy for ovarian and breast cancer prevention. Although bilateral oophorectomy may dramatically reduce the risk of gynecologic cancers, some studies suggested that bilateral oophorectomy may be associated with an increased risk of other types of cancer, such as lung cancer and colorectal cancer. However, the results are conflicting. OBJECTIVE: To study the association between bilateral oophorectomy and the risk of subsequent cancer of any type. STUDY DESIGN: This population-based cohort study included all premenopausal women who underwent bilateral oophorectomy for a nonmalignant indication before the age of 50, between January 1, 1988 and December 31, 2007 in Olmsted County, Minnesota, and a random sample of age-matched (±1 year) referent women who did not undergo bilateral oophorectomy. Women with cancer before oophorectomy (or index date) or within 6 months after the index date were excluded. Time-to-event analyses were performed to assess the risk of de novo cancer. Cancer diagnosis and type were confirmed using medical record review. RESULTS: Over a median follow-up of 18 years, the risk of any cancer did not significantly differ between the 1562 women who underwent bilateral oophorectomy before natural menopause and the 1610 referent women (adjusted hazard ratio, 0.82; 95% confidence interval, 0.66-1.03). However, women who underwent bilateral oophorectomy had a decreased risk of gynecologic cancers (adjusted hazard ratio, 0.15; 95% confidence interval, 0.06-0.34) but not of nongynecologic cancers (adjusted hazard ratio, 0.99; 95% confidence interval, 0.78-1.26). In particular, the risk of breast cancer, gastrointestinal cancer, and lung cancer did not differ between these 2 cohorts. Use of estrogen therapy through the age of 50 years in women who underwent bilateral oophorectomy did not modify the results. CONCLUSION: Women who underwent bilateral oophorectomy before menopause have a reduced risk of gynecologic cancer but not of other types of cancer including breast cancer. Women at average risk of ovarian cancer should not consider bilateral oophorectomy for the prevention of breast cancer or other nongynecologic cancers.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Huo N, Smith CY, Gazzuola Rocca L, et al. Risk of de novo cancer after premenopausal bilateral oophorectomy. Am J Obstet Gynecol. 2021. PMID: 34774521. doi:10.1016/j.ajog.2021.10.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。